About

Biomarker.org is part of the mission of Cancer Antibodies Inc. (CAI), a 501(c)(3) non-profit cancer research organization. We are focused on using novel methods to identify unique antigenic sites on cancer cells.

Our organization is a team of scientific researchers in cancer, biophysics, neuroscience, artificial intelligence and passionate advocates for advancements in cancer therapy.

Cancer is a global health emergency. Unfortunately, virtually all treatments that kill cancer cells adversely affect normal healthy cells, causing debilitating side effects.

Targeted immunotherapy is the leading approach for combating cancer. A key challenge has been to identify cancer-specific antigens that are suitable for antibody-based therapeutics.

Our cutting-edge Oncotope Platform has revolutionized the discovery of cancer-specific antigens. Remarkably, it can identify multiple new antigens on any cancer type in a matter of months.

Successful independent collaborations with multiple partners resulted in the identification of multiple new cell surface proteins (antigens) on breast cancer, including triple negative breast cancer, that have not been targeted before.

We welcome partners & collaborators that have an interest in making a difference in cancer research and would like to help carry this research to the clinic and start saving lives.